Infectious Optimism following the 10th International Oncolytic Virus Meeting

Matthew J. Atherton, Laura Evgin, Brian A. Keller, Mira M. Shenouda, Kyle B. Stephenson, Richard Geoffrey Vile, John C. Bell, David H. Evans, Brian D. Lichty

Research output: Contribution to journalArticle

Abstract

The 10th International Conference on Replicating Oncolytic Virus Therapeutics was held in Vancouver, Canada from October 1–4, 2016. The agenda for the meeting comprised lectures from several streams within the field of oncolytic viral therapeutics. Exploring the strengthening relationship among oncolytic viruses, cancer immunology, and immunotherapy; gaining an understanding for effective therapeutic delivery routes; and learning of exciting results from translational studies all featured prominently among areas discussed. As the field matures, commercialization and patient-centered research have become important avenues for growth; however, an abundance of high quality laboratory-based science continues to be performed in order to optimize future therapeutic approaches. Here, we summarize the latest innovations presented at this meeting.

Original languageEnglish (US)
Pages (from-to)12-16
Number of pages5
JournalMolecular Therapy - Oncolytics
Volume7
DOIs
StatePublished - Dec 15 2017

Fingerprint

Oncolytic Viruses
Therapeutics
Allergy and Immunology
Immunotherapy
Canada
Learning
Optimism
Growth
Research
Neoplasms

Keywords

  • cancer immunotherapy
  • clinical trials
  • oncolytic virus

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research
  • Pharmacology (medical)

Cite this

Atherton, M. J., Evgin, L., Keller, B. A., Shenouda, M. M., Stephenson, K. B., Vile, R. G., ... Lichty, B. D. (2017). Infectious Optimism following the 10th International Oncolytic Virus Meeting. Molecular Therapy - Oncolytics, 7, 12-16. https://doi.org/10.1016/j.omto.2017.08.004

Infectious Optimism following the 10th International Oncolytic Virus Meeting. / Atherton, Matthew J.; Evgin, Laura; Keller, Brian A.; Shenouda, Mira M.; Stephenson, Kyle B.; Vile, Richard Geoffrey; Bell, John C.; Evans, David H.; Lichty, Brian D.

In: Molecular Therapy - Oncolytics, Vol. 7, 15.12.2017, p. 12-16.

Research output: Contribution to journalArticle

Atherton, MJ, Evgin, L, Keller, BA, Shenouda, MM, Stephenson, KB, Vile, RG, Bell, JC, Evans, DH & Lichty, BD 2017, 'Infectious Optimism following the 10th International Oncolytic Virus Meeting', Molecular Therapy - Oncolytics, vol. 7, pp. 12-16. https://doi.org/10.1016/j.omto.2017.08.004
Atherton, Matthew J. ; Evgin, Laura ; Keller, Brian A. ; Shenouda, Mira M. ; Stephenson, Kyle B. ; Vile, Richard Geoffrey ; Bell, John C. ; Evans, David H. ; Lichty, Brian D. / Infectious Optimism following the 10th International Oncolytic Virus Meeting. In: Molecular Therapy - Oncolytics. 2017 ; Vol. 7. pp. 12-16.
@article{f192805862374821917be219796f92b4,
title = "Infectious Optimism following the 10th International Oncolytic Virus Meeting",
abstract = "The 10th International Conference on Replicating Oncolytic Virus Therapeutics was held in Vancouver, Canada from October 1–4, 2016. The agenda for the meeting comprised lectures from several streams within the field of oncolytic viral therapeutics. Exploring the strengthening relationship among oncolytic viruses, cancer immunology, and immunotherapy; gaining an understanding for effective therapeutic delivery routes; and learning of exciting results from translational studies all featured prominently among areas discussed. As the field matures, commercialization and patient-centered research have become important avenues for growth; however, an abundance of high quality laboratory-based science continues to be performed in order to optimize future therapeutic approaches. Here, we summarize the latest innovations presented at this meeting.",
keywords = "cancer immunotherapy, clinical trials, oncolytic virus",
author = "Atherton, {Matthew J.} and Laura Evgin and Keller, {Brian A.} and Shenouda, {Mira M.} and Stephenson, {Kyle B.} and Vile, {Richard Geoffrey} and Bell, {John C.} and Evans, {David H.} and Lichty, {Brian D.}",
year = "2017",
month = "12",
day = "15",
doi = "10.1016/j.omto.2017.08.004",
language = "English (US)",
volume = "7",
pages = "12--16",
journal = "Molecular Therapy - Oncolytics",
issn = "2372-7705",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Infectious Optimism following the 10th International Oncolytic Virus Meeting

AU - Atherton, Matthew J.

AU - Evgin, Laura

AU - Keller, Brian A.

AU - Shenouda, Mira M.

AU - Stephenson, Kyle B.

AU - Vile, Richard Geoffrey

AU - Bell, John C.

AU - Evans, David H.

AU - Lichty, Brian D.

PY - 2017/12/15

Y1 - 2017/12/15

N2 - The 10th International Conference on Replicating Oncolytic Virus Therapeutics was held in Vancouver, Canada from October 1–4, 2016. The agenda for the meeting comprised lectures from several streams within the field of oncolytic viral therapeutics. Exploring the strengthening relationship among oncolytic viruses, cancer immunology, and immunotherapy; gaining an understanding for effective therapeutic delivery routes; and learning of exciting results from translational studies all featured prominently among areas discussed. As the field matures, commercialization and patient-centered research have become important avenues for growth; however, an abundance of high quality laboratory-based science continues to be performed in order to optimize future therapeutic approaches. Here, we summarize the latest innovations presented at this meeting.

AB - The 10th International Conference on Replicating Oncolytic Virus Therapeutics was held in Vancouver, Canada from October 1–4, 2016. The agenda for the meeting comprised lectures from several streams within the field of oncolytic viral therapeutics. Exploring the strengthening relationship among oncolytic viruses, cancer immunology, and immunotherapy; gaining an understanding for effective therapeutic delivery routes; and learning of exciting results from translational studies all featured prominently among areas discussed. As the field matures, commercialization and patient-centered research have become important avenues for growth; however, an abundance of high quality laboratory-based science continues to be performed in order to optimize future therapeutic approaches. Here, we summarize the latest innovations presented at this meeting.

KW - cancer immunotherapy

KW - clinical trials

KW - oncolytic virus

UR - http://www.scopus.com/inward/record.url?scp=85041138103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041138103&partnerID=8YFLogxK

U2 - 10.1016/j.omto.2017.08.004

DO - 10.1016/j.omto.2017.08.004

M3 - Article

VL - 7

SP - 12

EP - 16

JO - Molecular Therapy - Oncolytics

JF - Molecular Therapy - Oncolytics

SN - 2372-7705

ER -